Koers Wound Management Technologies Inc Other OTC
Aandelen
US98211X1063
Farmaceutische producten
Omzet 2024 * | 78 mln. 72,54 mln. | Omzet 2025 * | - | Marktkapitalisatie | 281 mln. 261 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -930K | Nettowinst (verlies) 2025 * | 4 mln. 3,72 mln. | EV/omzet 2024 * | 3,6 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-148
x | K/w-verhouding 2025 * |
58,1
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 39,93% |
Recentste transcriptie over Wound Management Technologies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zach Fleming
CEO | Chief Executive Officer | 49 | 01-11-17 |
Michael McNeil
DFI | Director of Finance/CFO | 59 | 11-04-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 01-01-22 |
Roszell Mack
BRD | Director/Board Member | 57 | 01-01-22 |
Eric Major
BRD | Director/Board Member | 55 | 01-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,11% | 690 mld. | |
+26,43% | 546 mld. | |
-5,05% | 358 mld. | |
+18,39% | 323 mld. | |
+4,67% | 287 mld. | |
+14,32% | 235 mld. | |
+5,79% | 199 mld. | |
-9,49% | 195 mld. | |
+3,68% | 161 mld. |